Cancer screening in the United States, 2008: A review of current American Cancer Society guidelines and cancer screening issues

CA Cancer Journal for Clinicians

Volumn 58, Issue 3, 2008, Pages 161-179

  Smith, Robert A ^a   Cokkinides, Vilma ^a   Brawley, Otis Webb ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; WART VIRUS VACCINE;

BREAST CANCER; BREAST SELF EXAMINATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER FAMILY; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DIGITAL RECTAL EXAMINATION; ENDOMETRIUM CANCER; ETHNIC DIFFERENCE; FAMILY HISTORY; FECES ANALYSIS; GENETIC ANALYSIS; HEALTH INSURANCE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAMMOGRAPHY; MEDICAL AUDIT; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH SERVICE; REVIEW; SIGMOIDOSCOPY; SKIN CANCER; SURGICAL TECHNIQUE; UNITED STATES; UTERINE CERVIX CANCER;

AMERICAN CANCER SOCIETY; HUMANS; MASS SCREENING; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 45149131436     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/CA.2007.0017     Document Type: Review

References (81)

1. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000;50:34-49.
2. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-169.
3. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89.
4. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
5. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7-28.
6. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75.
7. Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin 2003;53:44-55.
8. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006;130:1865-1871.
9. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006;56:143-159.
10. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-160.
11. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
12. Tabár L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999;86:449-462.
13. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001;285:2750-2756.
14. Hartman AR. The problems with risk selection; scientific and psychosocial aspects. Recent Results Cancer Res 2005;166:125-144.
15. Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006;8:571-575.
16. Murff HJ, Byrne D, Syngal S. Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 2004;27:239-245.
17. Murff HJ, Greevy RA, Syngal S. The comprehensiveness of family cancer history assessments in primary care. Community Genet 2007;10:174-180.
18. Sabatino SA, McCarthy EP, Phillips RS, Burns RB. Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers. Cancer Detect Prev 2007;31:375-383.
19. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003;9:348-359.
20. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Recomm Rep 1995;44:1-34.
21. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003;124:544-560.
22. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-131.
23. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 2004;141:264-271.
24. Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc 2007;65:648-656.
25. Zitzelsberger L, Grunfeld E, Graham ID. Family physicians' perspectives on practice guidelines related to cancer control. BMC Fam Pract 2004;5:25.
26. Allison JE, Lawson M. Screening tests for colorectal cancer: a menu of options remains relevant. Curr Oncol Rep 2006;8:492-498.
27. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract 1997;45:211-218.
28. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:389-394.
29. Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005;142:81-85.
30. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 2005;142:86-94.
31. American College of Radiology Imaging Network. ACRIN Protocol 6656. Computerized Tomographic Colonography: Performance Evaluation in a Multicenter Setting. Available at: http://www.acrin.org/6656_protocol.html. Accessed July 1, 2007.
32. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006;56:160-167.
33. Walker JL, Nunez ER. Endometrial cancer, in Kramer BS, Gohagan JK, Prorok PC (eds). Cancer Screening: Theory and Practice. New York, NY: Marcel Dekker, Inc.; 1999:531-566.
34. Eddy D. Guidelines for the cancer related checkup: recommendations and rationale. CA Cancer J Clin 1980;30:194-240.
35. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
36. Ford LG, Minasian LM, McCaskill-Stevens W, et al. Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 2003;53:82-101.
37. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-597.
38. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771.
39. Maciosek MV, Coffield AB, Edwards NM, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006;31:52-61.
40. Health, United States, 2006 with Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2006.
41. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-560.
42. Hiatt RA, Klabunde C, Breen N, et al. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst 2002;94:1837-1846.
43. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Public Use Data Tape 2006. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention; 2006.
44. Research Triangle Institute. SUDAAN: Professional software for survey data analysis: user documentation for Release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
45. Nelson DE, Powell-Griner E, Town M, Kovar MG. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health 2003;93:1335-1341.
46. The Regents of the University of California. California Health Interview Survey. Available at: http://www.chis.ucla.edu/. Accessed November 14, 2007.
47. McCracken M, Olsen M, Chen MS Jr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007;57:190-205.
48. Breen N, A Cronin K, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer 2007;109:2405-2409.
49. Cram P, Fendrick AM, Inadomi J, et al. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 2003;163:1601-1605.
50. Saraiya M, Hall HI, Thompson T, et al. Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med 2004;39:308-314.
51. Robertson RH, Burkhardt JH, Powell MP, et al. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999-2001. Prev Med 2006;42:460-462.
52. Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol 2004;99:1544-1550.
53. McFall SL. US men discussing prostate-specific antigen tests with a physician. Ann Fam Med 2006;4:433-436.
54. Chan EC, Vernon SW, O'Donnell FT, et al. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health 2003;93:779-785.
55. Woolf SH, Krist AH, Johnson RE, Stenborg PS. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer. Patient Educ Couns 2005;56:116-124.
56. Lawson HW, Henson R, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep 2000;31:37-55.
57. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program Fact Sheet 2004/2005. Atlanta, GA: Centers for Disease Control and Prevention; 2005.
58. Carrasquillo O, Pati S. The role of health insurance on Pap smear and mammography utilization by immigrants living in the United States. Prev Med 2004;39:943-950.
59. Gorin SS, Heck JE. Cancer screening among Latino subgroups in the United States. Prev Med 2005;40:515-526.
60. Centers for Disease Control and Prevention. Colorectal cancer test use - Maryland, 2002-2006. MMWR Morb Mortal Wkly Rep 2007;56:932-936.
61. Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin 2007;57:354-366.
62. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007;9:R28.
63. Farria DM, Schmidt ME, Monsees BS, et al. Professional and economic factors affecting access to mammography: a crisis today, or tomorrow? Results from a national survey. Cancer 2005;104:491-498.
64. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007;57:90-104.
65. Carney PA, Goodrich ME, Mackenzie T, et al. Utilization of screening mammography in New Hampshire: a population-based assessment. Cancer 2005;104:1726-1732.
66. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-360.
67. Taplin SH, Ichikawa L, Yood MU, et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 2004;96:1518-1527.
68. Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin 2007;57:105-111.
69. Eltoum IA, Roberson J. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS). Cancer 2007;111:34-40.
70. Saraiya M, Irwin KL, Carlin L, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer 2007;110:1024-1032.
71. Institute of Medicine. Coverage Matters: Insurance and Health Care. Washington, DC: National Academy Press; 2001.
72. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008;58:9-31.
73. Busch SH, Duchovny N. Family coverage expansions: impact on insurance coverage and health care utilization of parents. J Health Econ 2005;24:876-890.
74. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107:1711-1742.
75. James TM, Greiner KA, Ellerbeck EF, et al. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis 2006;16:228-233.
76. DeNavas-Walt C, Proctor BD, Lee CH. Income, Poverty, and Health Insurance Coverage in the United States: 2004. Washington, DC: US Government Printing Office; 2005.
77. US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Periodic Update. Washington, DC: Agency for Healthcare Research and Quality; 2004.
78. Boulware LE, Marinopoulos S, Phillips KA, et al. Systematic review: the value of the periodic health evaluation. Ann Internal Medicine 2007;146:289-300.
79. Fenton JJ, Cai Y, Weiss NS, et al. Delivery of cancer screening: how important is the preventive health examination? Arch Intern Med 2007;167:580-585.
80. Maciosek MV, Edwards NM, Coffield AB, et al. Priorities among effective clinical preventive services: methods. Am J Prev Med 2006;31:90-96.
81. US Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: US Government Printing Office; 2000.